Clinical Importance of Objectionable Organisms

This webinar on objectionable microorganisms will show how to identify and prevent objectionable microorganisms that are beyond the ones outlined in USP <1111>. Attendees will learn the clinical implications due to presence of objectionable microorganisms.

Who will benefit:

This webinar will benefit companies in pharmaceuticals, biotechnology, medical devices and in-vitro diagnostics. The following personnel will benefit:

• Quality assurance
• Quality control microbiologists
• Microbiology laboratory personnel
• Manufacturing supervisors
• Clinical research professionals

Instructor Profile:

Ziva Abraham, President of Microrite, Inc., a San Jose, CA based consulting and training firm is a well known microbial contamination control expert with over 25 years of academic, research, clinical and industrial experience in Microbiology, and Quality Assurance. Her hands-on experience in varied fields has provided her with the framework to understand the effects of microbial contamination and quality pitfalls from a patient safety perspective.

Ziva received her Master’s Degree in Microbiology and has conducted graduate work on developing Microbial Insecticides. She has established clinical laboratory systems in Israel, and is involved in expanding Your Horizons, a program through the Math and Science Network to educate young girls about careers in science. She uses her hands on experience in varied fields to teach why assessing risk of microbial contamination should be in the forefront of any company that has products for human/veterinary use or to diagnose disease in humans and/or animals. Microrite, Inc. which was founded in 1998 helps Pharmaceutical, Medical Device, Biotechnology, and In Vitro Diagnostic companies in the areas of microbiological quality control for sterile and non-sterile manufacturing, quality systems procedures, GAP assessment, audits, preparation for inspections, process development, facilities, utilities and equipment validation.